Amanote Research
Register
Sign In
Platelet Thromboxane Inhibition by Plasma Polypeptides in Prehypertensive Dahl Rats.
Hypertension
- United States
doi 10.1161/01.hyp.8.6_pt_2.ii180
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Date
June 1, 1986
Authors
Y Uehara
L Tobian
J Iwai
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
Inhibition of Human Platelet Thromboxane Synthetase by 9,11-Azoprosta-5,13-Dienoic Acid.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Abnormal Platelet Function and Calcium Handling in Dahl Salt-Hypertensive Rats
Hypertension
Internal Medicine
Salt-Induced Plasma Factor That Inhibits Platelet Thromboxane A2 Release and Renal Prostaglandin E2 Production in Rats.
Hypertension
Internal Medicine
Thromboxane Generation by Human Monocytes Enhances Platelet Function
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Analysis of Metabolites in Plasma Reveals Distinct Metabolic Features Between Dahl Salt-Sensitive Rats and Consomic SS.13BN Rats
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Platelet Thromboxane A2 Synthetizing Activity in Ischemic Heart Disease
Blood & Vessel
Glucocorticoids Impair Platelet Thromboxane Biosynthesis in Community-Acquired Pneumonia
Pharmacological Research
Pharmacology
Inhibition of Thromboxane A2 Synthesis in Human Platelets by Coagulation Factor Xa.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Platelet Thromboxane Release After Subarachnoid Hemorrhage and Surgery
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing